ArticleDiscover oncology2025

Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort.

Yan Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.